Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RARE compared with CMPS: revenue, margins and what each company keeps, and the suppliers and customers both name
RARE
Ultragenyx Pharmaceutical Inc.
Change
Mkt cap
Revenue
Revenue
CMPS
COMPASS Pathways plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RARE
Ultragenyx Pharmaceutical Inc.
vs
CMPS
COMPASS Pathways plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only RARE
23
—
Undisclosed supplier
unlisted
supplier
TMO
Patheon Pharma Services by ThermoFisher Scientific
supplier
REGN
Regeneron Pharmaceuticals
supplier
BAX
Baxter Pharmaceutical Solutions
supplier
19 more · RARE chain
›
Shared
0
No disclosed counterparties: CMPS.
Only CMPS
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
RARE
Ultragenyx Pharmaceutical Inc.
Change
16.10
▼
−4.05%
· post 16.06
Mkt cap
$1.6B
Revenue
$214M
Q2 FY26
Revenue
$673M
FY25
CMPS
COMPASS Pathways plc
Change
11.57
▼
−5.09%
· post 11.62
Closed
Oct 30 '26
Mkt cap
$1.6B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
RARE
Ultragenyx Pharmaceutical Inc.
vs
CMPS
COMPASS Pathways plc
16.10
▼
−4.05%
post 16.06
Price
11.57
▼
−5.09%
post 11.62
$1.6B
Mkt cap
$1.6B
Q2 FY26
$214M
Revenue
—
FY25
$673M
Revenue
—
Change
Change
RARE
16.10
▼
−4.05%
vs
CMPS
11.57
▼
−5.09%
Closed
Oct 30 '26